CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $1.88B, above the global median of $1.15B
- PositionReturn on equity is -30.4%, lower than 95% of its Diagnostics & Research peers (median 2.9%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.88BUSDvs all stocks (USD)
Revenue (TTM)
442.68MUSDvs all stocks (USD)
Profit Margin
-17.58%vs Diagnostics & Research peers
Beta
1.91xvs all stocks
52-Week Change
-18.97%vs all stocks
Market Capitalization
1.88BUSDvs all stocks (USD)
Enterprise Value
1.88BUSDvs all stocks (USD)
Forward P/E
57.51xvs Diagnostics & Research peers
Price to Sales (TTM)
4.26xvs Diagnostics & Research peers
Price to Book (MRQ)
7.41xvs Diagnostics & Research peers
Enterprise to Revenue
4.25xvs Diagnostics & Research peers
Gross Margin
66.71%vs Diagnostics & Research peers
Profit Margin
-17.58%vs Diagnostics & Research peers
Operating Margin
-25.61%vs Diagnostics & Research peers
Return on Assets (TTM)
-4.37%vs Diagnostics & Research peers
Return on Equity (TTM)
-30.42%vs Diagnostics & Research peers
Revenue (TTM)
442.68MUSDvs all stocks (USD)
Revenue per Share (TTM)
15.30USDUpdated Jul 19, 2026Quarterly Revenue Growth
17.40%vs Diagnostics & Research peers
Gross Profit (TTM)
307.91MUSDvs all stocks (USD)
EBITDA (TTM)
13.35MUSDvs all stocks (USD)
Net Income (TTM)
-77.81MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
17.38%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
-9.31MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
3.64MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
427.54MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
129.37MUSDFY2025 · Dec 31, 2025Gross Profit
298.17MUSDFY2025 · Dec 31, 2025Operating Income
-13.08MUSDvs all stocks (USD)
Pre-tax Income
-21.14MUSDFY2025 · Dec 31, 2025Income Tax Expense
-116.00KUSDFY2025 · Dec 31, 2025Net Income
-21.02MUSDFY2025 · Dec 31, 2025EBIT
-13.08MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
13.35MUSDFY2025 · Dec 31, 2025Research & Development
72.03MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
239.22MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-21.02MUSDFY2025 · Dec 31, 2025Operating Cash Flow
21.04MUSDFY2025 · Dec 31, 2025Free Cash Flow
2.03MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
105.99MUSDFY2025 · Dec 31, 2025Income Tax Paid
1.27MUSDFY2025 · Dec 31, 2025Interest Paid
6.41MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-21.02MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
25.22MUSDFY2025 · Dec 31, 2025Stock-based Compensation
32.16MUSDFY2025 · Dec 31, 2025Other Non-cash Items
12.38MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-36.23MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
8.53MUSDFY2025 · Dec 31, 2025Capital Expenditures
-19.02MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
0.00USDFY2025 · Dec 31, 2025Net Acquisitions
-32.86MUSDFY2025 · Dec 31, 2025Purchase of Investments
-55.68MUSDFY2025 · Dec 31, 2025Sale of Investments
46.03MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-61.52MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-3.66MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
43.04MUSDFY2025 · Dec 31, 2025Shares Outstanding
29.67MSharesUpdated Jul 19, 2026Float Shares
18.94MSharesUpdated Jul 19, 2026Shares Short
5.94MSharesUpdated Jul 19, 2026Short Ratio
5.22daysvs all stocks
Short % of Shares Outstanding
38.46%vs all stocks
% Held by Insiders
12.31%vs all stocks
% Held by Institutions
115.43%vs all stocks
Total Cash (MRQ)
170.68MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
5.75USDUpdated Jul 19, 2026Total Debt (MRQ)
168.19MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.6619xvs Diagnostics & Research peers
Current Ratio (MRQ)
3.09xvs Diagnostics & Research peers
Book Value per Share (MRQ)
8.57USDUpdated Jul 19, 2026Total Assets
523.71MUSDvs all stocks (USD)
Total Current Assets
268.29MUSDFY2025 · Dec 31, 2025Total Liabilities
215.53MUSDFY2025 · Dec 31, 2025Total Non-current Assets
255.42MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
106.62MUSDFY2025 · Dec 31, 2025Total Current Liabilities
108.91MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
105.00MUSDFY2025 · Dec 31, 2025Other Short-term Investments
66.28MUSDFY2025 · Dec 31, 2025Accounts Receivable
74.37MUSDFY2025 · Dec 31, 2025Inventory
13.95MUSDFY2025 · Dec 31, 2025Accounts Payable
2.46MUSDFY2025 · Dec 31, 2025Short-term Debt
8.95MUSDFY2025 · Dec 31, 2025Other Current Liabilities
11.27MUSDFY2025 · Dec 31, 2025Long-term Debt
104.22MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
1.64MUSDFY2025 · Dec 31, 2025Common Stock (Book)
3.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-1.37BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
308.18MUSDvs all stocks (USD)
52-Week Low
32.21USDUpdated Jul 19, 202652-Week High
170.87USDUpdated Jul 19, 202652-Week Change
-18.97%vs all stocks
Beta
1.91xvs all stocks
50-Day MA
55.40USDUpdated Jul 19, 2026200-Day MA
93.85USDUpdated Jul 19, 2026Avg 10-Day Volume
676.85KSharesUpdated Jul 19, 2026Avg 30-Day Volume
967.71KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-2.74USDUpdated Jul 19, 2026Other Income / Expense
-5.52MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Depreciation-Heavy Reported Profit
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
Working Capital Pattern
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is -30.4%, lower than 95% of its Diagnostics & Research peers (median 2.9%)Significant
Return on equity: -0.30Industry median: 0.03Industry P5: -0.23Peers compared: 28.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.67Profit Margin: -0.18
Financial Health
Altman Z-Score 2.67: safe zoneNotable
Altman Z-Score: 2.67
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $1.88B, above the global median of $1.15BNotable
Market cap (USD): 1,884,595,953Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Solar Applied Materials Technology Corporation
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Infovision Optoelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Topband Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Winpak Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ecopro Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shenzhen Yinghe Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Willfar Information Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Shandong Pharmaceutical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Rongda Photosensitive Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Kin Yat Holdings Limited
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Lucky Strike Entertainment Co.
2 interpretationsDepreciation-Heavy Reported ProfitWorking Capital Pattern
Charming Medical Limited
2 interpretationsDepreciation-Heavy Reported ProfitWorking Capital Pattern
Molina Healthcare Inc.
1 interpretationDepreciation-Heavy Reported Profit